Trial Profile
The Clinical Study of Analgecine for the Treatment of Neuropathic Pain
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 May 2016
Price :
$35
*
At a glance
- Drugs AGC (Primary) ; Neurotropin
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Vanworld Pharmaceutical Rugao
- 22 Dec 2015 New trial record